We are live on
!
Find out more
IPW
Inlet Private Wealth Portfolio holdings
AUM
$392M
1-Year Est. Return
25.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+25.74%
3 Year Est. Return
+77.56%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$278M
AUM Growth
+$29.4M
(+12%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
7.45%
Top 10 Holdings %
Top 10 Hldgs %
33.23%
Holding
158
New
19
Increased
62
Reduced
28
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B&G Foods
BGS
|
+$3.37M |
| 2 |
Sony
SONY
|
+$3.23M |
| 3 |
PetMed Express
PETS
|
+$2.81M |
| 4 |
VISN
Vistance Networks Inc
VISN
|
+$2.77M |
| 5 |
Cardinal Health
CAH
|
+$1.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.89M |
| 2 |
MetLife
MET
|
+$2.33M |
| 3 |
Biogen
BIIB
|
+$2.23M |
| 4 |
ESV
Ensco Rowan plc
ESV
|
+$1.5M |
| 5 |
Franklin Resources
BEN
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.56% |
| 2 | Financials | 19.54% |
| 3 | Energy | 14.62% |
| 4 | Healthcare | 13.42% |
| 5 | Industrials | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
MetLife
MET
$61B
| – | – |
-54,647
| Closed | -$2.33M |
|
|
ACH
152
Accendra Health
ACH
$240M
| – | – |
-141,500
| Closed | -$580K |
|
153
Principal Financial Group
PFG
$23.6B
| – | – |
-4,400
| Closed | -$221K |
|
154
RTX Corp
RTX
$287B
| – | – |
-4,576
| Closed | -$371K |
|
155
Thomson Reuters
TRI
$39.4B
| – | – |
-3,703
| Closed | -$231K |
|
|
ENDP
156
DELISTED
Endo International plc
ENDP
| – | – |
-40,000
| Closed | -$321K |
|
|
ESV
157
DELISTED
Ensco Rowan plc
ESV
| – | – |
-95,100
| Closed | -$1.5M |
|
|
CELG
158
DELISTED
Celgene Corp
CELG
| – | – |
-30,605
| Closed | -$2.89M |
|
Similar funds
TCM
MA
BWM
SI
HBWM
S
EC
WSC
Inlet Private Wealth's Q2 2019 Portfolio in Review
As of Q2 2019, Inlet Private Wealth held 158 positions worth $278M, up 12% from $249M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Inlet Private Wealth deployed $20.7M of net new capital in Q2 2019, opening 19 new positions and adding to 62 existing holdings. Its largest new stake was B&G Foods: 146,100 shares worth $2.93M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was Franklin Resources, an estimated $1.13M trimmed.
- Inlet Private Wealth's largest Q2 2019 buy was B&G Foods: 146,100 shares worth $2.93M.
- Inlet Private Wealth added most to PetMed Express in Q2 2019, an estimated $2.81M increase.
- Inlet Private Wealth's biggest Q2 2019 reduction was Franklin Resources, cutting an estimated $1.13M.
- Inlet Private Wealth fully exited Celgene Corp in Q2 2019, selling an estimated $2.89M.
- Inlet Private Wealth's ten largest holdings make up 33% of its $278M portfolio in Q2 2019.
- Inlet Private Wealth opened 19 new positions and closed 12 in Q2 2019.
- Inlet Private Wealth's portfolio value rose 12% quarter-over-quarter to $278M.
Based on Inlet Private Wealth's 13F filing for Q2 2019, filed 22 Jul 2019.